Hp and pH: implications for the eradication of Helicobacter pylori
1Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada.
Abstract:
Helicobacter pylori infection causes inflammation of the gastric and duodenal mucosae, which results in a disturbance of the regulatory mechanisms for gastrin, gastric acid and pepsin secretion. Acid secretion may be decreased, normal or increased, depending on the stage of infection, although the meal-stimulated gastrin response is invariably elevated. The exact mechanisms involved are not known but may be due to the release of cytokines in response to bacterial toxins. H. pylori colonization is reduced by effective acid suppression with proton pump inhibitors, although it is not eradicated. In combination with amoxycillin, omeprazole, up to 40 mg twice daily, eradicated the organism in up to 82% of cases. This synergistic effect may be due to a direct effect of omeprazole on the organism, the protection of amoxycillin from acid degradation, or enhancement of host defence mechanisms accompanying acid suppression.
More Related Videos
06:40Quantitative Polymerase Chain Reaction (qPCR)-Based Rapid Diagnosis of Helicobacter pylori Infection and Antibiotic Resistance
Published on: July 28, 2023
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Peptic Ulcer
Gastritis II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
